Editas Medicine

EDIT Micro Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$2.67

+2.3% heute

52W: $0.91 – $4.54

52W Low: $0.91 Position: 48.5% 52W High: $4.54

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

6.45x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$261.3M

Marktkapitalisierung

Umsatzwachstum

-19.2%

YoY Umsatzwachstum

Gewinnmarge

—

Nettomarge

ROE

-198.14%

Eigenkapitalrendite

Beta

2.04

Marktsensitivität

Short Interest

11.8%

% der Aktien leerverkauft

Ø Volumen

1,759,032

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Kaufen

9 Analysten

Ø Kursziel

$5.50

+105.99% Upside

Kursziel Spanne

$1.00 – $13.00

Über das Unternehmen

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalassemia; and in vivo gene editing medicines indicated for other cells and tissues. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors, and autoimmune disease. The company was formerly known as Geng

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 87 Börse: NMS

Trading-Daten

50-Day MA: $2.14

200-Day MA: $2.59

Volumen: 1,107,549

Ø Volumen: 1,759,032

Short Ratio: 5.83

Kurs/Buchwert: 9.57x

Verschuldung/EK: 66.34x

Free Cash Flow: $-71,477,872

Wo kann ich Editas Medicine kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →